Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
NGHIÊN CỨU LÂM SÀNG Issue: Số 114 BỆNH SUY TIM

Prognostic value of the SCAI classification in patients with acute decompensated heart failure

Nguyễn Thị Thu Hương: Viện Tim mạch Việt Nam, Bệnh viện Bạch Mai; Phạm Mạnh Hùng: Trường Đại học Y Hà Nội; Hà Mai Hương: Bệnh viện Tim Hà Nội;
Published: May 30, 2025
Views: 208

Abstract

Objectives: (1) Classify cardiogenic shock stages in patients with acute decompensated heart failure using the Society for Cardiovascular Angiography and Interventions (SCAI) classification. (2) Investigate the 30-day mortality prognostic value of this classification among the study population.

Study Population and Methods: Prospective, observational study following patients with chronic heart failure admitted for acute decompensation at Bach Mai Cardiovascular Institute and Hanoi Heart Hospital. Collected clinical and paraclinical parameters upon admission, classified cardiogenic shock stages based on SCAI, and monitored patients for all-cause mortality over 30-days post-admission.

Results: Of 667 patients: 46.5% were SCAI stage A, 36.6% stage B, 15.4% stage C, 1.0% stage D, and 0.5% stage E. 30-days mortality was observed in 72 patients (10.8%). The SCAI classification was an independent mortality predictor with an HR of 2.69 (95% CI from 1.91 to 3.80; p < 0.001). Additional predictors included blood NT-proBNP levels, left ventricular ejection fraction, estimated pulmonary artery systolic pressure on echocardiography, and a history of stroke.

Conclusion: The SCAI classification is a practical tool in clinical settings, providing an independent prognostic value for 30-days mortality in patients with acute decompensated heart failure.

References

1.
Osman M, Syed M, Patibandla S, et al. Fifteen-Year Trends in Incidence of Cardiogenic Shock Hospitalization and In-Hospital Mortality in the United States. J Am Heart Assoc. 2021;10(15):e021061. doi:10.1161/JAHA.121.021061
2.
Thiele H, Jobs A, Ouweneel DM, et al. Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. Eur Heart J. 2017;38(47):3523-3531. doi:10.1093/eurheartj/ehx363
3.
Hunziker L, Radovanovic D, Jeger R, et al. Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry. Circ Cardiovasc Interv. 2019;12(4):e007293. doi:10.1161/CIRCINTERVENTIONS.118.007293
4.
Jentzer JC, van Diepen S, Barsness GW, et al. Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit. J Am Coll Cardiol. 2019;74(17):2117-2128. doi:10.1016/j.jacc.2019.07.077
5.
Berg DD, Bohula EA, Morrow DA. Epidemiology and causes of cardiogenic shock. Curr Opin Crit Care. 2021;27(4):401-408. doi:10.1097/mcc.0000000000000845
6.
Naidu SS, Baran DA, Jentzer JC, et al. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol. 2022;79(9):933-946. doi:10.1016/j.jacc.2022.01.018
7.
Olarte N, Rivera NT, Grazette L. Evolving Presentation of Cardiogenic Shock: A Review of the Medical Literature and Current Practices. Cardiol Ther. 2022;11(3):369-384. doi:10.1007/s40119-022-00274-6
8.
Pham MH, Ho TD, Vo TN, et al. Consensus of the Vietnam National Heart Association on the diagnosis and treatment of cardiogenic shock. Vietnam National Heart Association. 2023.
9.
Hill KL, Rustin MA, Asche MA, et al. Cardiogenic Shock Classification and Associated Mortality Risk. Mayo Clin Proc. 2023;98(5):771-783. doi:10.1016/j.mayocp.2022.12.007
10.
Thiele H, Freund A, Zeymer U, et al. Treatment of Heart Failure Related Cardiogenic Shock: When Treatment Is Dominated by Missing Clinical Evidence. JACC Heart Fail. 2023;11(2):188-190. doi:10.1016/j.jchf.2022.11.016
11.
Padkins M, Breen T, Anavekar N, et al. Age and shock severity predict mortality in cardiac intensive care unit patients with and without heart failure. ESC Heart Fail. 2020;7(6):3971-3982. doi:10.1002/ehf2.12995
12.
Jayagopal PB, Sastry SL, Nanjappa V, et al. Clinical characteristics and 30-day outcomes in patients with acute decompensated heart failure: Results from Indian College of Cardiology National Heart Failure Registry (ICCNHFR). Int J Cardiol. 2022;356:73-78. doi:10.1016/j.ijcard.2022.03.021

Files

Article Views208
Document Views0
Downloads0
Section NGHIÊN CỨU LÂM SÀNG
Issue Số 114
Category BỆNH SUY TIM